| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $257.6M | — | +27.5% |
| Cost of Revenue | $138.5M | — | +30.8% |
| Gross Profit | $119.1M | — | +23.9% |
| R&D Expense | $9.6M | — | +10.3% |
| SG&A Expense | $105.8M | — | +34.4% |
| Operating Income | $3.7M | — | -57.5% |
| Pre-tax Income | -$5.2M | — | -966.7% |
| Income Tax | -$1.8M | — | -1000.0% |
| Net Income | -$3.4M | — | -1233.3% |
| EPS (Basic) | -$0.01 | — | — |
| EPS (Diluted) | -$0.01 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $397.9M | -3.5% | +114.2% |
| Accounts Receivable | $181.5M | -0.1% | +22.8% |
| Inventory | $157.9M | +3.5% | +10.0% |
| Current Assets | $890.9M | -0.3% | +50.9% |
| Total Assets | $3.54B | -1.5% | +34.7% |
| Current Liabilities | $279.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $18.9M | — | -46.9% |
| Capital Expenditures | $9.5M | — | +11.8% |
| Investing Cash Flow | -$9.2M | — | -21.1% |
| Financing Cash Flow | -$19.9M | — | +6.1% |
| Free Cash Flow | $9.4M | — | -65.3% |
| +5.4% |
| Long-term Debt | $443.5M | +0.1% | -35.4% |
| Total Liabilities | $1.65B | -1.4% | +54.1% |
| Stockholders' Equity | $1.84B | -1.5% | +22.2% |